Company Filing History:
Years Active: 2023
Title: Anselm De Souza: Innovator in Vitamin K2 Research
Introduction
Anselm De Souza is an innovative inventor based in Mumbai, India, recognized for his contributions to the field of medical science. His research notably emphasizes the therapeutic potential of Vitamin K2 in addressing drug-induced neuropathy, specifically in patients undergoing treatment for multiple myeloma. This groundbreaking work has the potential to improve the quality of life for many patients dealing with the side effects of their treatments.
Latest Patents
Anselm De Souza holds a patent for his invention titled "Vitamin K2 compositions for the treatment of drug-induced neuropathy." The patent focuses on the use of Vitamin K2-7 compositions to mitigate the effects of drug-induced peripheral neuropathy, a condition that can significantly affect patients undergoing certain cancer treatments. This innovative approach highlights the therapeutic benefits of Vitamin K2 in a clinical context.
Career Highlights
Currently, Anselm is associated with Synergia Life Sciences Pvt. Ltd., a company dedicated to developing advanced medical solutions. His work at Synergia Life Sciences contributes to the advancement of pharmaceutical research and the development of innovative treatments. Anselm's unique approach in utilizing Vitamin K2 reflects his commitment to addressing complex health challenges.
Collaborations
Throughout his career, Anselm has collaborated with distinguished colleagues in the field. Notable coworkers include Dilip S Mehta and Ashok Vaidya. These collaborations often lead to enhanced research outputs, fostering a multidisciplinary approach to tackling medical issues associated with drug therapies.
Conclusion
Anselm De Souza stands out as a significant figure in the realm of medical innovations. His patent on Vitamin K2 compositions showcases his forward-thinking approach to solving critical health problems faced by patients. As research in this field continues to evolve, Anselm’s contributions will likely play a crucial role in improving treatment outcomes and enhancing patient care in the realm of cancer therapy.